Halozyme Therapeutics shares owned by Advisors Preferred
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Advisors Preferred
from 13F filings
Historical chart of Advisors Preferred investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Advisors Preferred consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Advisors Preferred
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.5M | 20k | 74.94 |
| 2025-03-31 | $3.4M | 56k | 61.87 |
| 2024-12-31 | $2.0M | 42k | 48.01 |
| 2024-06-30 | $5.1M | 97k | 52.02 |
| 2024-03-31 | $1.0M | 25k | 41.32 |
| 2022-12-31 | $364k | 6.6k | 55.13 |
| 2022-09-30 | $317k | 7.9k | 39.98 |
| 2022-06-30 | $355k | 8.1k | 44.05 |
| 2022-03-31 | $455k | 11k | 41.60 |
| 2021-03-31 | $2.9M | 68k | 42.43 |
| 2020-12-31 | $1.7M | 39k | 42.41 |